Related Experiment Video
Updated: May 24, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Development of a Digitally Applicable Tool for Identifying Insulin Adherence Challenges Prior to Consultation
Jannie Nørlev1,2, Stine Hangaard1,2
1Department of Health Science and Technology, Aalborg University, Gistrup, Denmark.
Studies in Health Technology and Informatics
|May 23, 2026
Summary
A new 10-item questionnaire effectively assesses insulin therapy adherence in diabetes patients. This tool helps identify adherence challenges for better glycemic control and personalized patient support.
Area of Science:
- Endocrinology
- Diabetes Management
- Psychometrics
Background:
- Insulin therapy is vital for diabetes management and glycemic control.
- Non-adherence to insulin treatment is prevalent and difficult to identify.
- Accurate assessment tools are needed to address insulin adherence barriers.
Purpose of the Study:
- To develop and validate a Danish questionnaire for assessing insulin adherence.
- To ensure the questionnaire captures key aspects of insulin-taking behavior.
- To provide a reliable tool for clinical and educational applications.
Main Methods:
- A 10-item questionnaire was developed using literature review and expert input.
- Content validity was assessed by five domain experts using a 4-point relevance scale.
- Item-level Content Validity Index (I-CVI), Scale-level CVI (S-CVI/Ave), and kappa statistics (κ*) were calculated.
Main Results:
- All 10 items achieved perfect relevance scores (I-CVI = 1.00, κ* = 1.00) from all experts.
- The questionnaire demonstrated excellent overall content validity (S-CVI/Ave).
- The tool comprehensively covers various facets of insulin-taking behavior.
Conclusions:
- The developed questionnaire exhibits strong content validity for measuring insulin adherence.
- This tool can aid healthcare professionals in identifying adherence issues.
- Digital administration prior to consultations can optimize patient support and education.
Related Concept Videos
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...